Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In experimental wound healing models, TB-500 treatment increases capillary density by 40-50% while improving functional blood flow restoration, demonstrating translation of cellular angiogenic activity into meaningful tissue-level perfusion benefits
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P
Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)
Vieta E, Valent M
Available Sizes: GHK-Cu is supplied as a high-purity blue lyophilized powder in multiple sizes to support different research scales or experimental protocols
As of early 2026, no peer-reviewed human clinical trials for TB-500 specifically have been published
US$ 25.30
US$ 29.81
US$ 28.57
US$ 25.69
US$ 20.95
US$ 22.31
